Abstract:HCA-7 human colorectal cancer cells were transfected with miRNA precursor forms, pre-miR-143 or pre-miR-145; or c-Myc siRNA or scrambled oligonucleotides using Lipofectamine.Colon cancer cell or colonic fibroblast EGFR was activated with EGF or inhibited with C225 anti-EGFR antibodies.Western blotting was used to assess G1 cell cycle regulators: c-Myc, cdk6, cyclin D2, E2F3 and pRb.Northern blotting and real time PCR were used to measure miR-143 and miR-145.Cell proliferation and DNA synthesis were measured by WST-1 and BrdU incorporation, respectively.Results: Northern blotting confirmed low levels of miR-143 and miR-145 in human colon cancers and cell lines.As in the case of human cancers, miR-143 and miR-145 were down-regulated 90% in colonic tumors of mice with wt EGFR.In striking contrast, these miRNA were increased 4-5-fold in tumors from Wa2 Egfr mice.Wa2 mutations nearly abolish receptor kinase activity In Vitro.Up-regulations of pre-miR-143 or pre-miR-145 by transfection caused 60-70% reduction in proliferation and inhibited DNA synthesis by 80-90% in HCT116 cells, consistent with a tumor suppressor role for these miRNA.Modulating EGFR signals caused parallel changes in c-Myc, while inducing inverse changes in miR-143 and miR-145 in cancer cells (C225-treated) and fibroblasts (EGF-treated).c-Myc siRNA knock-down also increased miR-143 and miR-145 by 50-95% in cancer cells, while decreasing c-Myc ~90%, suggesting c-Myc mediates EGFR suppression of these miRNAs.Compared to control, EGF increased cdk6, pRb and E2F3, whereas C225 antibodies reduced these proteins in cancer cells, identifying these G1 regulators as EGFR targets.In contrast, pre-miR-143 and pre-miR-145 reduced these G1 regulators by 30-60% in HCT116 cells, suggesting they are also functional targets of miR-143 and miR-145.Conclusion: These studies suggest that EGFR proliferation is mediated by c-Myc via inhibition of miR-143 and miR-145.Furthermore, we have demonstrated for the first time that these miRNA negatively control G1 cell cycle regulators.

Microrna-141 Inhibits Tumor Growth and Minimizes Therapy Resistance in Colorectal Cancer

MicroRNA-206 Attenuates Tumor Proliferation and Migration Involving the Downregulation of NOTCH3 in Colorectal Cancer.

1069 MicroRNA-143 is a Potential Tumor Suppressor Targeting DNA Methyltransferases 3a in Colorectal Cancer

Microrna-187 Inhibits Tumor Growth and Invasion by Directly Targeting Cd276 in Colorectal Cancer

MicroRNA-143 inhibits tumor growth and angiogenesis and sensitizes chemosensitivity to oxaliplatin in colorectal cancers.

Microrna-17-5p Promotes Chemotherapeutic Drug Resistance And Tumour Metastasis Of Colorectal Cancer By Repressing Pten Expression

Mir-139-5p Inhibits the Epithelial-Mesenchymal Transition and Enhances the Chemotherapeutic Sensitivity of Colorectal Cancer Cells by Downregulating BCL2

MicroRNA-141-3p Affected Proliferation, Chemosensitivity, Migration and Invasion of Colorectal Cancer Cells by Targeting EGFR.

MiR-141 inhibits colorectal cancer cell proliferation and invasion by targeting PRKAR 1 A

MicroRNA-34a: Potent Tumor Suppressor, Cancer Stem Cell Inhibitor, and Potential Anticancer Therapeutic

MiR-139-5p Reverses CD44+/CD133+-associated Multidrug Resistance by Downregulating NOTCH1 in Colorectal Carcinoma Cells

MiR-7-5p/KLF4 Signaling Inhibits Stemness and Radioresistance in Colorectal Cancer.

Mir-449B Inhibits the Proliferation of SW1116 Colon Cancer Stem Cells Through Downregulation of CCND1 and E2F3 Expression

MicroRNA-145 Inhibits Tumorigenesis and Invasion of Cervical Cancer Stem Cells.

Mir‐137 Targets Cdc42 Expression, Induces Cell Cycle G1 Arrest and Inhibits Invasion in Colorectal Cancer Cells

Downregulation of Mir-1 in Colorectal Cancer Promotes Radioresistance and Aggressive Phenotypes.

MicroRNAs (miRNAs): Novel potential therapeutic targets in colorectal cancer

Microrna-137 Inhibits Tumor Growth And Sensitizes Chemosensitivity To Paclitaxel And Cisplatin In Lung Cancer

MicroRNA as regulators of cancer stem cells and chemoresistance in colorectal cancer.

Mir-942-5p Inhibits Proliferation, Metastasis, and Epithelial-Mesenchymal Transition in Colorectal Cancer by Targeting CCBE1

Tumor-suppressive Microrna-195-5p Regulates Cell Growth and Inhibits Cell Cycle by Targeting Cyclin Dependent Kinase 8 in Colon Cancer.